Deutsche Bank’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Buy	376,867 +79,363	+27%	+$307K	﹤0.01%	2098
2025 Q4	$1.22M	Buy	297,504 +27,945	+10%	+$138K	﹤0.01%	2092
2025 Q3	$1.32M	Buy	269,559 +29,872	+12%	+$157K	﹤0.01%	2005
2025 Q2	$1.21M	Buy	239,687 +33,317	+16%	+$164K	﹤0.01%	1977
2025 Q1	$1.09M	Sell	206,370 -11,353	-5%	-$82.8K	﹤0.01%	2104
2024 Q4	$1.47M	Buy	217,723 +75,994	+54%	+$511K	﹤0.01%	2026
2024 Q3	$934K	Buy	141,729 +31,852	+29%	+$228K	﹤0.01%	2148
2024 Q2	$824K	Buy	109,877 +28,795	+36%	+$251K	﹤0.01%	2093
2024 Q1	$808K	Buy	81,082 +2,735	+3%	+$30.5K	﹤0.01%	2114
2023 Q4	$773K	Buy	78,347 +18,659	+31%	+$133K	﹤0.01%	2161
2023 Q3	$457K	Buy	59,688 +7,973	+15%	+$79.5K	﹤0.01%	2225
2023 Q2	$386K	Sell	51,715 -36,945	-42%	-$259K	﹤0.01%	2500
2023 Q1	$591K	Buy	88,660 +17,687	+25%	+$140K	﹤0.01%	2397
2022 Q4	$547K	Buy	70,973 +12,903	+22%	+$127K	﹤0.01%	2400
2022 Q3	$618K	Sell	58,070 -6,248	-10%	-$63.3K	﹤0.01%	2262
2022 Q2	$523K	Sell	64,318 -1,481	-2%	-$9.91K	﹤0.01%	2566
2022 Q1	$471K	Sell	65,799 -7,002	-10%	-$74.4K	﹤0.01%	2789
2021 Q4	$1.25M	Buy	72,801 +56,039	+334%	+$1.05M	﹤0.01%	2304
2021 Q3	$385K	Buy	16,762 +3,640	+28%	+$103K	﹤0.01%	3202
2021 Q2	$479K	Buy	+13,122	New	+$388K	﹤0.01%	3252